Verrica Pharmaceuticals Inc (VRCA) Stock Price, Quote, News & History

VRCANASDAQ
$5.69
0.6212.23%
At close: Aug 28, 5:00 PM EST
$5.73
0.03720.65%
After Hours: Aug 28, 7:01 PM EST
Loading...

Key Statistics

Open
$5.12
Close
$5.69
Volume / Avg.
351.92K / 54.33K
Day Range
$5.00 - $5.86
52 Wk Range
3.28 - 9.82
Market Cap
$98.39M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
62
Short Interest
3.05%
Days to Cover
5.16

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-13.35M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
9.41M
Free Cash Flow (TTM)
-13.35M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-3.94M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$87.67M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.82
PB Ratio (TTM)
20.62
Earnings Yield % (TTM)
-33.66%
Earnings Yield % (FWD)
-42.36%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.25

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$48.26M
Total Cash
$11.20M
Debt to Equity
0.42
Issuance of Debt (TTM)
-$48.26M
Repayment of Debt (TTM)
-$40.23M

Key Statistics

Open
$5.12
Close
$5.69
Volume / Avg.
351.92K / 54.33K
Day Range
$5.00 - $5.86
52 Wk Range
3.28 - 9.82
Market Cap
$98.39M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
62
Short Interest
3.05%
Days to Cover
5.16

About

Sector
Health Care
Industry
Pharmaceuticals
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Verrica Pharmaceuticals (VRCA) stock?

A

You can purchase shares of Verrica Pharmaceuticals (NASDAQ:VRCA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Verrica Pharmaceuticals (VRCA) competitors?

Q

What is the forecast, or price target, for Verrica Pharmaceuticals (VRCA) stock?

A

Verrica Pharmaceuticals has a consensus price target of $9.83.

Q

What is the current price for Verrica Pharmaceuticals (VRCA)?

A

The stock price for Verrica Pharmaceuticals (NASDAQ: VRCA) is $5.7272 last updated August 28, 2026 at 7:01 PM EDT.

Q

Does Verrica Pharmaceuticals (VRCA) pay a dividend?

A

There are no upcoming dividends for Verrica Pharmaceuticals.

Q

When is Verrica Pharmaceuticals (NASDAQ:VRCA) reporting earnings?

A

Verrica Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Verrica Pharmaceuticals (VRCA) going to split?

A

There is no upcoming split for Verrica Pharmaceuticals.

Q

What sector and industry does Verrica Pharmaceuticals (VRCA) operate in?

A

Verrica Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.